Poly lactic acid (PLA) nanoparticles sustain the cytotoxic action of temozolomide in C6 Glioma cells

Biomedicine and Aging Pathology

Volumn 3, Issue 4, 2013, Pages 201-208

  Jain, Darshana S ^a   Athawale, Rajani B ^a   Bajaj, Amrita N ^b   Shrikhande, Shruti S ^a   Goel, Peeyush N ^c   Nikam, Yuvraj ^c   Gude, Rajiv P ^c  

^a SNDT WOMEN S UNIVERSITY   (India)

^b SVKM S DR BHANUBEN NANAVATI COLLEGE OF PHARMACY   (India)

^c TATA MEMORIAL HOSPITAL   (India)

Author keywords

Blood brain barrier; C6 glioma cells; Glioblastoma; PLA nanoparticles; Temozolomide

Indexed keywords

POLYLACTIC ACID; TAUROGLYCOCHOLIC ACID; TEMOZOLOMIDE;

ARTICLE; CELL MOTILITY; CLONOGENESIS; CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FORMULATION; DRUG UPTAKE; EVAPORATION; GLIOMA CELL; PARTICLE SIZE; PRIORITY JOURNAL;

EID: 84889084880     PISSN: 22105220     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomag.2013.08.003     Document Type: Article

References (23)

1. J.F. Deeken, and W. Loscher The blood-brain barrier and cancer: transporters, treatment, and Trojan horses Clin Cancer Res 13 2007 1663 1674
2. H. Hope Crusade. Brain Tumor Guide for the Newly Diagnosed: Version 6 2009 CreateSpace Independent Publishing Platform
3. A.M. Butt, H.C. Jones, and N.J. Abbott Electrical resistance across the blood-brain barrier in anaesthetized rats: a developmental study J Physiol 429 1990 47 62
4. D.R. Groothuis The blood-brain and blood-tumor barriers: a review of strategies for increasing drug delivery Neuro Oncol 2 2000 45 59
5. K.M. Mahar Doan, J.E. Humphreys, L.O. Webster, S.A. Wring, L.J. Shampine, and C.J. Serabjit-Singh Passive permeability and P-glycoprotein-mediated efflux differentiate central nervous system (CNS) and non-CNS marketed drugs J Pharmacol Exp Ther 303 2002 1029 1037
6. N.J. Abbott, L. Ronnback, and E. Hansson Astrocyte-endothelial interactions at the blood-brain barrier Nat Rev Neurosci 7 2006 41 53
7. M.F. Stevens, J.A. Hickman, S.P. Langdon, D. Chubb, L. Vickers, and R. Stone Antitumor activity and pharmacokinetics in mice of 8-carbamoyl-3-methyl- imidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one (CCRG 81045; M & B 39831), a novel drug with potential as an alternative to dacarbazine Cancer Res 47 1987 5846 5852
8. L.L. Tsang, C.P. Quarterman, A. Gescher, and J.A. Slack Comparison of the cytotoxicity in vitro of temozolomide and dacarbazine, prodrugs of 3-methyl-(triazen-1-yl)imidazole-4-carboxamide Cancer Chemother Pharmacol 27 1991 342 346
9. V.A. Trinh, S.P. Patel, and W.J. Hwu The safety of temozolomide in the treatment of malignancies Expert Opin Drug Saf 8 2009 493 499
10. X.H. Tian, X.N. Lin, F. Wei, W. Feng, Z.C. Huang, and P. Wang Enhanced brain targeting of temozolomide in polysorbate-80 coated polybutylcyanoacrylate nanoparticles Int J Nanomed 6 2011 445 452
11. N. Nerkar, A. Bajaj, S. Shrikhande, and D. Jain Fabrication of lipospheres for paclitaxel and assessment of in vitro cytotoxicity against U373 cancer cell lines Thai J Pharm Sci 36 2012 117 130
12. D. Jain, R. Athawale, A. Bajaj, S. Shrikhande, P.N. Goel, and R.P. Gude Studies on stabilization mechanism and stealth effect of poloxamer 188 onto PLGA nanoparticles Colloids Surf B Biointerfaces 109 2013 59 67
13. M. Karelson, D. Dobchev, T. Tamm, I. Tulp, J. JÃnes, and K. TÃmm Correlation of blood-brain penetration and human serum albumin binding with theoretical descriptors Arkivoc 16 2008 38 60
14. N.A. Franken, H.M. Rodermond, J. Stap, J. Haveman, and C. van Bree Clonogenic assay of cells in vitro Nat Protocol 1 2006 2315 2319
15. C.S. Pichot, S.M. Hartig, L. Xia, C. Arvanitis, D. Monisvais, and F.Y. Lee Dasatinib synergizes with doxorubicin to block growth, migration, and invasion of breast cancer cells Br J Cancer 101 2009 38 47
16. P.N. Goel, and R.P. Gude Unravelling the antimetastatic potential of pentoxifylline, a methylxanthine derivative in human MDA-MB-231 breast cancer cells Mol Cell Biochem 358 2011 141 151
17. P. Dua, and R.P. Gude Antiproliferative and antiproteolytic activity of pentoxifylline in cultures of B16F10 melanoma cells Cancer Chemother Pharmacol 58 2006 195 202
18. H.S. Lee, E.Y. Seo, N.E. Kang, and W.K. Kim [6]-Gingerol inhibits metastasis of MDA-MB-231 human breast cancer cells J Nutr Biochem 19 2008 313 319
19. H. Chen, L. Wang, J. Yeh, X. Wu, Z. Cao, and Y.A. Wang Reducing non-specific binding and uptake of nanoparticles and improving cell targeting with an antifouling PEO-b-PgammaMPS copolymer coating Biomaterials 31 2010 5397 5407
20. E. Frohlich The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles Int J Nanomed 7 2012 5577 5591
21. D. Hanahan, and R.A. Weinberg Hallmarks of cancer: the next generation Cell 144 2011 646 674
22. G. Ramis, E. Thomas-Moya, S. Fernandez de Mattos, J. Rodriguez, and P. Villalonga EGFR inhibition in glioma cells modulates Rho signaling to inhibit cell motility and invasion and cooperates with temozolomide to reduce cell growth PLoS One 7 2012 e38770
23. M. Chen, A.E. Rose, N. Doudican, I. Osman, and S.J. Orlow Celastrol synergistically enhances temozolomide cytotoxicity in melanoma cells Mol Cancer Res 7 2009 1946 1953